Contrasting evolutionary trajectories of pyrimethamine resistance in human and zoonotic malaria parasites. [PDF]
Putaporntip C +5 more
europepmc +1 more source
<i>Plasmodium falciparum</i> field isolates drug susceptibility in Mali. [PDF]
Maiga FO +11 more
europepmc +1 more source
Bilateral visual impairment caused by Toxoplasma gondii encephalitis and ocular GVHD in a patient after allo-HSCT. [PDF]
Eraghi AT, Pleyer U, Dietrich-Ntoukas T.
europepmc +1 more source
Nephrolithiasis associated with sulfadiazine therapy in an infant with congenital toxoplasmosis: a case report. [PDF]
Wen Y, Nie Y.
europepmc +1 more source
Emergence of Plasmodium falciparum pfdhps A581G mutation in Southern Senegal under Seasonal Malaria Chemoprevention pressure, 2020-2023. [PDF]
Diallo MA +17 more
europepmc +1 more source
Editorial: Advancing chemotherapy against protozoan parasites: development and repurposing of therapeutic compounds. [PDF]
Mariante RM +3 more
europepmc +1 more source
Salts of Antifolate Pyrimethamine with Isomeric Aminobenzoic Acids: Exploring Packing Interactions and Pre-Crystallization Aggregation. [PDF]
Cichocka K +4 more
europepmc +1 more source
Antimalarial drug resistance in <i>Plasmodium falciparum</i> isolates from the Pacific Coast of Colombia. [PDF]
Michie K +6 more
europepmc +1 more source
Molecular markers of antimalarial drug resistance in pfk13, pfmdr1, pfdhfr, and pfdhps genes of Plasmodium falciparum in a rural municipality in Cubal, Benguela Province, Angola (2022-2023). [PDF]
Mediavilla A +15 more
europepmc +1 more source
Mechanistic perspectives on antimalarial agents: from FDA-approved drugs to next-generation candidates. [PDF]
Monika, Sharma B, Awasthi SK.
europepmc +1 more source

